Featured News

CC Diagnostics and partners receive 600K SNN-EFRO subsidy

🚀 CC Diagnostics & partners receive a €600K subsidy grant! Thanks to the support of Samenwerkingsverband Noord-Nederland (SNN) our team can further develop the Methica CC kit to solve the current challenges in cervical cancer screening. 🔬 With our trusted partners UMCG, MolGen and IQ Products we will bring molecular screening to the next level.

CC Diagnostics Completes Methica CC Clinical Validation Study with Groundbreaking Results

CC Diagnostics has successfully completed a large clinical validation study using samples from the Dutch National Screening Program. The results? **97% sensitivity for cancer detection**, outperforming the pap smear by **21%**—all without compromising specificity. This study, conducted across multiple centers, reflects real-world performance and eliminates bias, marking a significant leap forward in cervical cancer diagnostics.

CC Diagnostics enters EIT Health Catapult Semifinals

🎉We’re thrilled to announce that CC Diagnostics was selected as one of 30 trailblazing European start-ups in the prestigious EIT Catapult! With this program's support, we’re more energized than ever to advance cervical cancer screening and make a global impact on women’s healthcare.

News by Year

There are no articles available for the selected year.